Destiny Pharma plc services

Work on earlier programmes investigating infections in areas such as respiratory, dermal, ocular and biofilms carries on as research projects, including academic and/or commercial collaborations and grant funded programmes.

The company is focused on the clinical development and commercial exploitation through partnering of its highly innovative anti-infective portfolio and has an open door policy to discussing potential business relationships. These range from partnering and licensing through to investment and non-dilutive funding as well as risk sharing and joint ventures with industry, academia and governments.